When was Argá Medtech founded?

Argá Medtech was founded in 2020 and raised its 1st funding round 4 years after it was founded.

Where is Argá Medtech located?

Argá Medtech is headquartered in Epalinges, Switzerland.

How many employees does Argá Medtech have?

As of Jun 30, 2026, the latest employee count at Argá Medtech is 39.

Is Argá Medtech a funded company?

Argá Medtech is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Feb 27, 2024.

When was the latest funding round of Argá Medtech?

Argá Medtech's latest funding was a $***** Series B round on Feb 27, 2024, with participation from 3 investors. Its primary sector is Cardiac and Vascular Disorders. In Switzerland, the Cardiac and Vascular Disorders sector has seen $33.3M in funding in 2026 to date.

Where does Argá Medtech rank among its competitors?

Argá Medtech ranks 7th amongst 19 active competitors, of which 12 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Pulsecare Medical Technology, which secured $14M in Nov, 2025.

Who are the top competitors of Argá Medtech?

Argá Medtech's top competitors include Kardium, Galvanize and Field Medical. Among them, Pulsecare Medical Technology secured the most recent funding round in November, 2025.

Argá Medtech - 2026 Company Profile, Team, Funding & Competitors

Argá Medtech is a series B company based in Epalinges (Switzerland), founded in 2020 by Randy Werneth. It operates as a Developer of medical devices for treating cardiac arrhythmias. Argá Medtech has raised $58.5M in funding from Earlybird and Advent Life Sciences. The company has 19 active competitors, including 12 funded and 3 that have exited. Its top competitors include companies like Kardium, Galvanize and Field Medical.

Company Details

Developer of medical devices for treating cardiac arrhythmias. The company is developing the next generation of Pulsed Field Ablation and Irreversible Electroporation devices for treating cardiac arrhythmias.

Website: argamedtech.com
Social

Key Metrics

Founded Year

2020

Location

Epalinges, Switzerland

Stage

Series B

Total Funding

$58.5M in 1 round

Latest Funding Round

Series B, Feb 27, 2024, $*****

Investors

Earlybird & 2 more

Ranked

7^th among 19 active competitors

Employee Count

39 as on Jun 30, 2026

Similar Companies

Kardium & 17 more

View Argá Medtech's full profile

Argá Medtech has raised a total funding of $58.5M over 1 round. Its latest funding round was a Series B round on Feb 27, 2024 for $*****. 3 investors participated in its latest round. Argá Medtech has 3 institutional investors.

Here is the list of recent funding rounds of Argá Medtech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 27, 2024	1984646	Series B	7611165	3305952	5913207	8053363

Access funding benchmarks and valuations. Sign up today!

View details of Argá Medtech's funding rounds and investors

The founders of Argá Medtech is Randy Werneth.

Here are the details of Argá Medtech's key team members:

Randy Werneth: Co-Founder & CTO of Argá Medtech and founder of 2 other companies, Acutus Medical and CryoTherapeutics.

View details of Argá Medtech's Founder profiles and Board Members

Argá Medtech's employee count trend

Argá Medtech has 39 employees as of Jun 26. Here is Argá Medtech's employee count trend over the years:

Uncover Argá Medtech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Argá Medtech include Kardium, Galvanize and Field Medical. Here is the list of Top 10 competitors of Argá Medtech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Kardium 2007, Burnaby (Canada), Series C	Developer of ablation device for atrial fibrillation	$471M	Fidelity Investments, T. Rowe Price & 10 others	65/100
2nd	Galvanize 2020, San Carlos (United States), Series C	Developer of pulsed electric field systems for various medical indications	$210M	Fidelity Investments, Sofinnova Partners ... & 11 others	58/100
3rd	Field Medical 2022, Encinitas (United States), Series B	Developer of device for the treatment of heart arrhythmia conditions	$89M	BioStar Capital, Cue Growth Partners	56/100
4th	Pulse Biosciences 2014, Burlingame (United States), Acquired	Developer of a platform technology called Nano-Pulse Electro-Signaling	$8M	MDB Capital, Sea Purity Investments & 1 others	50/100
5th	Pulsecare Medical Technology 2021, Shenzhen (China), Series A	Developer of medical device solutions for heart and vascular care	$14M	Oriza Holdings, Loayal Valley Capital & 3 others	50/100
6th	Affera 2014, Boston (United States), Acquired	Developer of devices to treat heart rhythm disorders	-	Innogest Capital, Bain Capital Life Sciences ... & 4 others	47/100
7th	Argá Medtech 2020, Epalinges (Switzerland), Series B	Developer of medical devices for treating cardiac arrhythmias	$58.5M	Gilde Healthcare, Advent Life Sciences & 1 others	45/100
8th	Farapulse 2014, Menlo Park (United States), Series C	Advanced cardiac ablation solutions for atrial fibrillation treatment	$36.3M	F-Prime Capital, Boston Scientific & 3 others	42/100
9th	EnChannel Medical 2020, Ladera Ranch (United States), Series B	Developer of medical device for cardiac disorders	$110M	LAV, DragonBall Capital & 2 others	39/100
10th	AtriAN 2017, Galway (Ireland), Seed	Developing the device that targets to atrial fibrillation	$2.56M	Western Development Commission, Mayo Clinic Ventures ... & 4 others	34/100